Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
03/2003
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1095930B1 Novel compounds
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003CN1406223A Protease inhibitor and their pharmaceutical uses
03/25/2003US6538152 Obesity, hyperglycemia, urinary incontinence, intestinal or biliary calculi hypermotility, pollakiuria and depression treatment
03/20/2003WO2003022810A1 3-amino carbonyl-substituted benzoylcyclohexanediones that can be used as herbicides
03/20/2003WO2003022798A1 Heat-sensitive compounds having a cloud point which can be used as extractants for the separation of metals in aqueous solution
03/20/2003WO2003004457A3 Preparation process for atorvastatin and intermediates
03/20/2003WO2003004455A3 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives, intermediates thereof and methods for their preparation
03/20/2003WO2002085841A3 Substituted catechol derivatives derived from polybasic secondary amino acids, method for production and use thereof
03/20/2003US20030055287 Phthalic acid diamide derivatives, fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055087 As analgesic
03/19/2003EP1293497A1 Process for the production of calcium pantothenate
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292567A1 Novel beta-hydroxyamides
03/19/2003EP0944636B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
03/19/2003CN1404466A Stabilizing agent for hydroxylamine solutions
03/19/2003CN1103332C Biphenyl-5-alkanoic acid derivative and is application
03/18/2003US6534532 Carbanilides as pesticides
03/18/2003US6534513 Phenylalkanoic acid derivatives
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/13/2003WO2003020688A1 Selective protein tyrosine phosphatase inhibitors
03/13/2003WO2002044128A3 Salicylate analogs as interleukin-4 antagonists
03/12/2003EP1289936A1 Substituted stilbenes as glucose uptake enhancers
03/12/2003EP1036058B1 Adamantane derivatives
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402614A High selective herbicidal phenoxypropionic acid alkoxycarbonyl anilid compounds and method of preparing thereof
03/12/2003CN1102925C Bis-(aminocarbonylnaphthol) derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003CA2210579C Benzene derivatives
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018537A1 Antiviral protease inhibitors
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2002046160A3 Process for making a thrombin inhibitor
03/06/2003US20030045742 Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
03/06/2003US20030045726 Novel immunotherapeutic agents
03/06/2003US20030045579 Compounds and compositions for delivering active agents
03/06/2003US20030045560 6-(Aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
03/06/2003US20030045432 Phenyl-substituted cyclic ketoenols
03/06/2003CA2458040A1 Antiviral protease inhibitors
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003CN1400969A Fused imidazolium derivatives
03/05/2003CN1102661C Resolution of racemic amino esters by enzyme-catalyzed cylation
03/04/2003US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
03/04/2003US6528525 Amidocarboxylic acid derivatives
02/2003
02/27/2003WO2003016923A2 Hydroxypyridonate and hydroxypyrimidinone chelating agents
02/27/2003WO2003016266A1 β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF
02/27/2003WO2002055011A3 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof
02/27/2003CA2456161A1 Hydroxypyridonate and hydroxypyrimidinone chelating agents
02/26/2003EP1285908A1 Substituted phenylpropionic acid derivatives
02/26/2003EP1285651A1 Melanin concentrating hormone antagonists
02/26/2003EP1284960A1 Cyclic amino acid derivatives useful as pharmaceutical agents
02/26/2003EP1284724A1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
02/26/2003CN1399687A Method for producing optically active amines
02/26/2003CN1399628A Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives
02/25/2003US6525219 4-amino-2-hydroxy-5-substituted-acylanilide compounds and method of using them
02/25/2003US6525020 For drug delivery
02/21/2003WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/21/2003CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient
02/20/2003WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
02/20/2003WO2003014063A2 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
02/20/2003WO2003014058A1 Alkylenebisnaphtol derivatives and charge control agent comprising the same
02/20/2003WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses
02/20/2003WO2002024635A3 Aminoalcohol derivatives
02/20/2003US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor.
02/20/2003US20030036532 Treatment of infections caused by parasites, especially malaria.
02/20/2003CA2456255A1 Protected 3.5-dihydroxy-2.2-dimethyl-valeroamides for the synthesis of epothilone and derivatives and method for the production and use thereof
02/20/2003CA2455754A1 Amine derivatives
02/19/2003EP0946685B1 Lubricity additives for fuel oil compositions
02/19/2003CN1101805C key intermediates in mfg. of simvastatin
02/18/2003US6521666 Inhibitors of α4 mediated cell adhesion
02/18/2003US6521658 Cell proliferation inhibitors
02/18/2003US6521603 Fungicides for the control of take-all disease of plants
02/18/2003US6521432 Methods for enhancing the rate of modification of metastable bonds
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/13/2003WO2003011816A1 Process for obtaining n-monosubstituted amides
02/13/2003WO2002067761A3 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
02/13/2003US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
02/13/2003US20030029712 Azeotropic distillation process for producing organic acids or organic acid amides
02/13/2003US20030029711 Mixing a feed stream and at least one azeotroping agent; decomposing the ammonium salt, the amide, or the alkylamine-organic acid complex to produce organic acid producing a first vapor stream; separating
02/12/2003EP1283039A1 -secretase inhibitors
02/12/2003EP1282595A1 Novel phenyl-propargylether derivatives
02/12/2003EP1080065A4 A method of permanent fluorescent assay
02/12/2003EP1032566B1 Method for the preparation of citalopram
02/11/2003US6518450 Guaiacoxypropanolamines with alpha/beta adrenergic blocking activity
02/11/2003US6518283 Squaric acid derivatives
02/11/2003US6518036 Method of permanent fluorescent assay
02/11/2003CA2250391C Butadiene derivatives and process for their preparation
02/06/2003WO2003010132A1 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives
02/06/2003WO2003010122A1 Interfacial method of preparing ester-substituted diaryl carbonates
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003US20030027862 Amino-and amido-diphenyl ethers
02/06/2003US20030027861 6-Methoxy-2-naphthylacetic acid prodrugs
02/06/2003US20030027860 6-Methoxy-2-naphthylacetic acid prodrugs
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
02/06/2003US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC
02/06/2003US20030027189 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis
02/06/2003US20030026751 Stabilizing agent for hydroxylamine solutions
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 157